Found 24 matching trials
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients NA The goal of this clinical trial is to compare responses to Varicella Zoster...
Show More Location
Royal Adelaide Hospital
Learn More & Join Trial
A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) PHASE3 The purpose of the sutdy is to evaluate the protective efficacy of Recombin...
Show More Status
Active Not Recruiting
Location
Hebei Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Vaccine Responses in Patients With B Cell Malignancies PHASE4 Background:
People with B cell malignancies (blood cancers) often cannot m...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I) PHASE2 Background:
People who have cancer tend to get sick more often. This is in...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications PHASE4 This multi-center study will evaluate the safety and immune response to rec...
Show More Learn More & Join Trial
Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above PHASE1 The purposes of the study are to evaluate the safety and tolerability of di...
Show More Status
Active Not Recruiting
Location
Yanjin District Center for Disease Control and Prevention
Learn More & Join Trial
Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older PHASE3 The purpose of the sutdy is to evaluate efficacy, safety and immunogenicity...
Show More Status
Active Not Recruiting
Location
Hebei Provincial Center for Disease Control and Prevention
Learn More & Join Trial
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and Older PHASE2 This phase 2 study in China will evaluate the immunogenicity and safety of ...
Show More Status
Active Not Recruiting
Location
Hengnan County Center for Disease Control and Prevention
Learn More & Join Trial
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older PHASE1 This phase 1 study in China will evaluate the safety and immunogenicity of ...
Show More Location
Guangdong Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Multidisciplinary Hospital-Territory Vaccine Center: a Model for Achieving the Herpes Zoster Vaccine Coverage N/A The National Vaccination Program, updated by the Ministry of Health in 2021...
Show More Location
Fondazione Policlinico Universitario A. Gemelli - UCSC
Learn More & Join Trial